Open Access


Read more
image01

Online Manuscript Submission


Read more
image01

Submitted Manuscript Trail


Read more
image01

Online Payment


Read more
image01

Online Subscription


Read more
image01

Email Alert



Read more
image01

Original Research Article | OPEN ACCESS

Anti-asthmatic effect of fusarubin in an ovalbumin-induced asthmatic rat model

Jiajing Hong1, Fuchun Wang1, Dongyu Yang2, Junming Kan3

1College of Acupuncture and Massage, The Affiliated of Changchun University of Traditional Chinese Medicine, Changchun, Jilin 130117, China; 2Department of Traditional Chinese Medicine, The Affiliated of Changchun University of Traditional Chinese Medicine, ChaChangchun, Jilin 130117, China; 3College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, Jilin 130117, China.

For correspondence:-  Junming Kan   Email: 394327974@qq.com   Tel:+8643186172513

Accepted: 24 December 2021        Published: 31 January 2022

Citation: Hong J, Wang F, Yang D, Kan J. Anti-asthmatic effect of fusarubin in an ovalbumin-induced asthmatic rat model. Trop J Pharm Res 2022; 21(1):87-92 doi: 10.4314/tjpr.v21i1.14

© 2022 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To investigate the anti-asthmatic effect of fusarubin in an ovalbumin (OVA)-induced asthmatic rat model
Methods: A rat model of asthma was employed in this investigation. Ovalbumin (OVA) was used to sensitise rats, and the rats were then treated with fusarubin before the onset of asthma. Histology-based examinations were conducted to assess the impact of fusarubin on mucus secretion and migration of eosinophils into the lungs.
Results: The results showed that fusarubin significantly decreased ovalbumin-induced airway hyperresponsiveness {AHR levels of inflammatory cells and eosinophils in bronchoalveolar lavage fluid (BALF)}, when compared to the control group (p < 0.05). Furthermore, fusarubin markedly downregulated levels of OVA-stimulated pro-inflammatory cytokines in BAL fluid (p < 0.05).
Conclusion: Fusarubin may be used as a potential novel compound for the management of asthma.

Keywords: Asthma, Hypersensitivity, Fusarubin, Inflammatory cells, Eosinophil, Airway hyperresponsiveness, Bronchoalveolar lavage, Cytokines

Impact Factor
Thompson Reuters (ISI): 0.6 (2023)
H-5 index (Google Scholar): 49 (2023)

Article Tools

Share this article with



Article status: Free
Fulltext in PDF
Similar articles in Google
Similar article in this Journal:

Archives

2024; 23: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10. 
2023; 22: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12. 
2022; 21: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12. 
2021; 20: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12. 
2020; 19: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12. 
2019; 18: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12. 
2018; 17: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12. 
2017; 16: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12. 
2016; 15: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12. 
2015; 14: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12. 
2014; 13: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12. 
2013; 12: 
1,   2,   3,   4,   5,   6. 
2012; 11: 
1,   2,   3,   4,   5,   6. 
2011; 10: 
1,   2,   3,   4,   5,   6. 
2010; 9: 
1,   2,   3,   4,   5,   6. 
2009; 8: 
1,   2,   3,   4,   5,   6. 
2008; 7: 
1,   2,   3,   4. 
2007; 6: 
1,   2,   3,   4. 
2006; 5: 
1,   2. 
2005; 4: 
1,   2. 
2004; 3: 
1. 
2003; 2: 
1,   2. 
2002; 1: 
1,   2. 

News Updates